Evidence Hub

Quercetin's Multifaceted Role in Alzheimer's Disease, Melanoma, and Tuberculosis: A Systematic Review with Preclinical Insights

Mahendra Pratap Swain, Satyajit Mohanty, Nayan Gupta, Tuhin Mukherjee, Sandeep Kumar Singh, A. Pattnaik

Current pharmaceutical design, 2026

Abstract

INTRODUCTION

Quercetin, a polyphenolic flavonoid that is abundant in fruits and vegetables, demonstrates substantial antioxidant, anti-inflammatory, immunomodulatory, and anti-cancer properties. It has garnered attention for its therapeutic potential in tuberculosis (TB), melanoma cancer, and Alzheimer's disease (AD).

METHODS

Following PRISMA 2020 guidelines, a systematic review was conducted using PubMed, Scopus, and Web of Science databases (2000-2024). The focus was on approaches to improve bioavailability, with an examination of preclinical models, pharmacological mechanisms, and therapeutic outcomes.

RESULTS

Quercetin reduced β-amyloid aggregation (45-60%), improved cognitive performance by up to 50%, and mitigated oxidative stress by nearly 50% in Alzheimer's models. In melanoma, it promoted apoptosis, inhibited angiogenesis (45% reduction), and decreased tumor volume by 40-60% in preclinical studies. In TB models, quercetin enhanced macrophage autophagy (30% increase), decreased bacterial burden by 40-60% and synergistically improved the efficacy of rifampicin by 35-40%. Addressing its bioavailability challenge (<1% in native form), nanotechnology-based delivery systems increased quercetin's absorption up to 10-fold, with certain systems achieving absolute bioavailability improvements of 30-35%.

DISCUSSION

Preclinical findings consistently highlight quercetin's multitargeted role in modulating oxidative stress, inflammation, apoptosis, and immune responses across…

How strong is the evidence?

Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free